Tea catechins with a galloyl moiety reduce body weight and fat

被引:55
作者
Kajimoto, O
Kajimoto, Y
Yabune, M
Nakamura, T
Kotani, K
Suzuki, Y
Nozawa, A
Nagata, K
Unno, T
Sagesaka, YM
Kakuda, T
Yoshikawa, T
机构
[1] Osaka Univ Foreign Studies, Hlth Management Ctr, Osaka 5628558, Japan
[2] Soiken Inc, Dept Clin Trials & Res, Osaka 5600082, Japan
[3] Osaka Univ, Grad Sch Med Res Mol Control Internal Med, Osaka 5650871, Japan
[4] Osaka Kenkou Club, Sekiyama Clin, Osaka 5640063, Japan
[5] ITOEN Ltd, Cent Res Inst, Shizuoka 4210516, Japan
[6] Kyoto Med Sch, Dept Internal Med, Kamikyo Ku, Kyoto 6028566, Japan
关键词
tea catechin; body fat; obesity; clinical trial;
D O I
10.1248/jhs.51.161
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
We investigated the effect of consumption of a catechin-containing drink on body fat level and its safety in healthy adults. The beverage (250 ml/bottle) contained 215.3 mg of tea catechins mostly possessing a galloyl moiety, which included (-)-epigallocatechin gallate 74.6 mg, (-)-epicatechin gallate 34.1 mg, (-)-gallocatechin gallate 77.8 mg. (-)-catechin gallate 24.5 mg. We conducted a double-blind study with three parallel groups. Healthy subjects (98 men and 97 women) aged from 20 to 65 years old with 22.5 < body mass index (BMI) <= 30 kg/m(2) were assigned to consume 3 bottles of placebo drink (control group), 2 bottles of catechin-containing drink and I bottle of placebo drink (low-dose group), or 3 bottles of catechin-containing drink (high-dose group), per day at mealtimes for 12 week (daily consumption of catechins was 41.1, 444.3 or 665.9 mg respectively). Compared to the value at 0 week, consumption of two or three bottles of catechin-containing drink results in significant decrease in body weight and BMI at 8 and 12 or 4, 8 and 12 week, respectively. Body weight and BMI was significantly decreased in both catechin groups compared with the control group from 4 to 12 week. The measurements of abdominal fat areas indicated significant reduction of total fat area and visceral fat area in both catechin groups compared with the control group at 12 week. Thus our present observations suggest that consumption of a catechin-containing drink may be useful for the prevention of obesity-related disorders.
引用
收藏
页码:161 / 171
页数:11
相关论文
共 38 条
[1]   CAFFEINE AND COFFEE - THEIR INFLUENCE ON METABOLIC-RATE AND SUBSTRATE UTILIZATION IN NORMAL WEIGHT AND OBESE INDIVIDUALS [J].
ACHESON, KJ ;
ZAHORSKAMARKIEWICZ, B ;
PITTET, P ;
ANANTHARAMAN, K ;
JEQUIER, E .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1980, 33 (05) :989-997
[2]  
Asaka M, 2000, J JPN SOC FOOD SCI, V47, P708, DOI 10.3136/nskkk.47.708
[3]   CAFFEINE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ITS THERMOGENIC, METABOLIC, AND CARDIOVASCULAR EFFECTS IN HEALTHY-VOLUNTEERS [J].
ASTRUP, A ;
TOUBRO, S ;
CANNON, S ;
HEIN, P ;
BREUM, L ;
MADSEN, J .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1990, 51 (05) :759-767
[4]   Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet [J].
Chan, PT ;
Fong, WP ;
Cheung, YL ;
Huang, Y ;
Ho, WKK ;
Chen, ZY .
JOURNAL OF NUTRITION, 1999, 129 (06) :1094-1101
[5]   Degradation of green tea catechins in tea drinks [J].
Chen, ZY ;
Zhu, QY ;
Tsang, D ;
Huang, Y .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2001, 49 (01) :477-482
[6]   Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity [J].
Dulloo, AG ;
Seydoux, J ;
Girardier, L ;
Chantre, P ;
Vandermander, J .
INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (02) :252-258
[7]  
Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
[8]   Cancer inhibition by green tea [J].
Fujiki, H ;
Suganuma, M ;
Okabe, S ;
Sueoka, N ;
Komori, A ;
Sueoka, E ;
Kozu, T ;
Tada, Y ;
Suga, K ;
Imai, K ;
Nakachi, K .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1998, 402 (1-2) :307-310
[9]   CONTRIBUTION OF INTRAABDOMINAL FAT ACCUMULATION TO THE IMPAIRMENT OF GLUCOSE AND LIPID-METABOLISM IN HUMAN OBESITY [J].
FUJIOKA, S ;
MATSUZAWA, Y ;
TOKUNAGA, K ;
TARUI, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (01) :54-59
[10]   CYCLIC SEASONAL-VARIATION IN PLASMA-LIPID AND LIPOPROTEIN LEVELS - THE LIPID RESEARCH CLINICS CORONARY PRIMARY PREVENTION TRIAL PLACEBO GROUP [J].
GORDON, DJ ;
HYDE, J ;
TROST, DC ;
WHALEY, FS ;
HANNAN, PJ ;
JACOBS, DR ;
EKELUND, LG .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (07) :679-689